Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies

Diabetes

Volumn 47, Issue 9, 1998, Pages 1399-1405

  Mottram, Patricia L ^a   Murray Segal, Lisa J ^b   Han, Wenruo ^c   Maguire, Julie ^b   Stein Oakley, Alicia ^b   Mandel, Thomas E ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 4; OKT 8;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; INSULITIS; ISOGRAFT; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0031685794     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1399     Document Type: Article

References (38)

1. Stratta R, Sudan D, Jerius J, Cashing K, Frisbie K, Radio S: Graft survival after solitary pancreas transplantation (Abstract). In American Society of Transplant Physicians. Chicago, IL, Slack Publishers, 1997, p. 102
2. Sutherland DE, Gruessner A, Mouldry-Munns K: International pancreas registry report. Transplant Proc 26:407-411, 1994
3. Sutherland DE, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38 (Suppl. 1):85-87, 1089
4. Terada M, Lennartz K, Mullen Y: Allogeneic and syngeneic pancreas transplantation in nonobese diabetic mice. Transplant Proc 19:960-961, 1987
5. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37:930-935, 1988
6. + T-lymphocytes. Diabetes 37:1108-1112, 1988
7. Chatenoud L, Thervet E, Primo J, Bach JF: Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody. C R Acad Sci III 315:225-228, 1992
8. Shizuru JA, Alters SE, Fathman CG: Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunol Rev 129:10-5-130, 1992
9. Matsuo S, Mullen Y, Wicker LS, Peterson LB, Nagata M, Tsunoda T, Clare-Salzler M: Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies. Transplant Proc 22:880-881, 1990
10. Mottram PL, Wheelahan J, McKenzie IF, Clunie GJ: Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly2 antibodies. Transplant Proc 19:2898-2901, 1987
11. Mottram PL, Purcell LJ, Kalina SL: Microsurgical techniques for transplantation of vascularized organs in mice. In Experimental Transplantation Models in Small Animals. Green MK, Mandel TE, Eds. Melbourne, Australia, Gordon and Breach Science Publishers, 1995, p. 175-195
12. Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch FW: Characterization of the murine T-cell surface molecule, designated L3T4, identified by the monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131:2445-2450, 1983
13. Ledbetter J, Herzenberg LA: Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:64-74, 1979
14. Purcell LJ, Mottram PL: Prevention of both rejection and recurrence of autoimmune disease in the NOD/Lt mouse following segmental pancreas transplantation. Transplant Proc 27:2166-2167, 1995
15. + T-cells. Transplantation 54:483-490, 1992
16. Stein-Oakley A, Maguire J, Dowling J, Perry G, Thomson N: Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis. Kidney Int 51:195-204, 1997
17. Mottram PL, Purcell LJ, Ban WR, Maguire J, Stein-Oakley AN: IL-4, the cytokine that isn't there: reactivity of IL-4 antibodies with cells in IL-4 -/- mice. Transplantation 63:911-914, 1997
18. Sander B, Hoiden I, Anderssen U, Moller E, Abrams JS: Similar frequencies and kinetics of cytokine-producing cells in murine peripheral blood and spleen. J Immunol Methods 166:201-214, 1994
19. Räisänen-Sokolowski A, Mottram P, Glysing-Jensen T, Satoskar A, Russell M: Heart transplants in interferon-γ, interleukin-4, and interleukin-10 knockout mice: recipient environment alters graft rejection. J Clin Invest 100:2449-2456, 1997
20. Mandel TE, Kovarik J, Koulmanda M: A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosupressed nonobese diabetic mice. Am J Pathol 147:834-844, 1995
21. Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW: Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 59:559-565, 1995
22. Cobbold SP, Qin S, Leong LYW, Martin G, Waldmann H: Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev 129:164-210, 1992
23. Mendola JF, Goity C, Fernandez-Alvarez J, Saenz A, Benarroch G, Fernandez-Cruz L, Gomis R: Immunocytochemical study of pancreatic islet revascularization in islet isograft. Transplantation 57:725-730, 1994
24. Sutherland DE, Gores PF, Farney AC, Wahoff DC, Matas AJ, Dunn DL, Gruessner RW, Najarian JS: Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg 166:456-491, 1993
25. Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 165:1639-1654, 1987
26. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr: CD8 T-cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76, 1996
27. Charlton B, Bacelj A, Slattery RM, Mandel TE: Cyclophosphamide-induced diabetes in NOD/WEHI mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38:441-447, 1989
28. McLaren N, Lafferty K: The 12th International Immunology and Diabetes Workshop: Orlando, Florida. Diabetes 42:1099-1104, 1993
29. Matsuo S, Mullen Y, Wicker LS, Peterson LB, Nagata M: Islet destruction by the NOD mouse may be mediated by both MHC-restricted and nonrestricted mechanisms. Transplant Proc 23:743-744, 1991
30. Terada M, Salzler M, Lennartz K, Mullen Y: The effect of H-2 compatibility on pancreatic β-cell survival in the nonobese diabetic mouse. Transplantation 45:622-627, 1988
31. Mandel TE, Koulmanda M, Bacelj A: Fetal pancreas transplantation in nonobese diabetic (NOD) mice: a comparison of iso-, allo- and xenografts. Horm Metab Res (Suppl 25): 166-173, 1990
32. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL: Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am J Pathol 147:1193-1199, 1995
33. Kreis H: Adverse effects associated with OKT3 immunosuppression in the prevention or treatment of allograft rejection. Clin Transplantation 7:431-438, 1993
34. Dun SH, Yoon JW: Studies on autoimmunity for initiation of β-cell destruction. VI. Macrophages essential for development of β-cell-specific cytotoxic effectors and insulitis in NOD mice. Diabetes 39:1273-1278, 1990
35. Benhamou PY, Mullen Y, Clare-Salzler M, Sangkharat A, Benhamou C, Shevlin L, Go VL: Essential fatty acid deficiency prevents autoimmune diabetes in nonobese diabetic mice through a positive impact on antigen-presenting cells and Th2 lymphocytes. Pancreas 11:26-37, 1995
36. Shehadah N, LaRosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of diabetes. J Autoimmunity 6:291-300, 1993
37. Rapaport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: Interleukin-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
38. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF: IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882, 1995